Urinary analyte screening: A noninvasive detection method for Down syndrome?

Molecular Medicine Today

Volumn 5, Issue 2, 1999, Pages 68-73

  Canick, Jacob A ^a   Kellner, Leonard H ^b   Cole, Laurence A ^c   Cuckle, Howard S ^d  

^a BROWN UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CHORIONIC GONADOTROPIN; ESTRIOL;

AMNIOCENTESIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOWN SYNDROME; FEMALE; HIGH RISK POPULATION; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; MATERNAL AGE; PRENATAL SCREENING; REVIEW; SECOND TRIMESTER PREGNANCY; URINALYSIS;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0033082326     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(98)01396-3     Document Type: Review

References (29)

1. Tabor, A. et al. (1986) Randomised controlled trial of genetic amniocentesis in 4606 low-risk women, Lancet I, 1287-1293
2. Merkatz, I.R., Nitowsky, H.M., Macri, J.N. and Johnson, W.E. (1984) An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities, Am. J. Obstet. Gynecol. 148, 886-894
3. Cuckle, H.S., Wald, N.J. and Lindenbaum, R.H. (1984) Maternal serum alpha-fetoprotein measurement: A screening test for Down's syndrome, Lancet I, 926-929
4. Bogart, M.H., Pandian, M.R. and Jones, O.W. (1987) Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities, Prenatal Diagn. 7, 623-630
5. Macri, J.N. et al. (1990) Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin, Am. J. Obstet. Gynecol. 163, 1248-1253
6. Canick, J.A. et al. (1994) Maternal serum dimeric inhibin is elevated in Down syndrome pregnancy, Am. J. Hum. Genet. 55, A9
7. Canick, J.A. et al. (1988) Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome, Br. J. Obstet. Gynaecol. 95, 330-333
8. Wald, N.J., Kennard, A., Hackshaw, A. and McGuire, A. (1997) Antenatal screening for Down's syndrome, J. Med. Screening 4, 181-246
9. Wald, N. et al. (1996) Prenatal screening for Down's syndrome using inhibin-A as a serum marker, Prenatal Diagn. 16, 143-153
10. Yen, S.S.C. (1994) Endocrinology of pregnancy, in Maternal Fetal Medicine, Principles and Practice (3rd Edn), (Creasy, R.K. and Resnik, R., eds), pp. 382-412, Saunders
11. Cole, L.A. et al. (1991) The heterogeneity of hCG. III. The occurrence, biological and immunological activities of nicked hCG, Endocrinology 129, 1559-1568
12. Cole, L.A., Kardana, A., Park, S.Y. and Braunstein, G.D. (1993) The deactivation of hCG by nicking and dissociation, J. Clin. Endocrinol. Metab. 76, 704-710
13. Elliott, M.M., Kardana, A., Lustbader, J.W. and Cole, L.A. (1997) Carbohydrate and peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma, Endocrine 7, 15-32
14. Cuckle, H.S., Iles, R.K. and Chard, T. (1994) Urinary β-core human chorionic gonadotropin: A new approach to Down's syndrome screening, Prenatal Diagn. 14, 953-958
15. Rotmensch, S. et al. (1996) Peptide heterogeneity of human chorionic gonadotropin (hCG) and its β-subunit in Down syndrome pregnancies, Am. J. Obstet. Gynecol. 166, 354-360
16. Canick, J.A. et al. (1995) Second trimester levels of maternal urinary gonadotroin peptide in Down syndrome pregnancy, Prenatal Diagn. 15, 752-759
17. Cuckle, H.S. et al. (1995) Urinary multiple marker screening for Down's syndrome, Prenatal Diagn. 15, 745-751
18. Cole, L.A. et al. New screening tests for fetal Down syndrome: I. Fresh urine β-core fragment, Prenatal Diagn. (in press)
19. Isozaki, T., Palomaki, G.E., Bahado-Singh, R.O. and Cole, L.A. (1997) Screening for Down syndrome using β-core fragment: Prospective study, Prenatal Diagn. 17, 407-413
20. Cole, L.A. et al. (1997) Comparison of 12 assays for detecting hGC and related molecules in urine samples from Down syndrome pregnancies, Prenat. Diagn. 17, 607-614
21. Birken, S. et al. (1988) Structure of human chorionic gonadotropin β-subunit core fragment from pregnancy urine, Endocrinology 123, 572-580
22. Cole, L.A. et al. (1998) Hyperglycosylated hCG, a potential alternative to hGC in Down syndrome screening, Prenatal Diagn. 18, 926-933
23. Cole, L.A. et al. New screening tests for fetal Down syndrome: II. Hyperglycosylated hGC , Prenatal Diagn. (in press)
24. Kellner, L.H. et al. (1997) Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome, Prenatal Diagn. 17, 1135-1142
25. Cole, L.A. et al. (1997) Combining β-core fragment and total oestriol measurement to test for Down syndrome pregnancies, Prenatal Diagn. 17, 1125-1134
26. Canick, J.A. et al. (1996) A second level evaluation of maternal urinary gonadotropin peptide as a marker for second trimester Down syndrome screening, in 3rd Joint Clinical Genetics Meeting, A156, March of Dimes Birth Defects Foundation and the American College of Medical Genetics
27. Lam, Y.H. et al. (1997) Second-trimester maternal urinary gonadotrophin peptide screening for fetal Down syndrome in Asian women, Prenatal Diagn. 17, 1101-1106
28. Spencer, K., Aitken, D.A., Macri, J.N. and Buchanan, P.D. (1996) Urine free beta hGC and beta core in pregnancies affected by Down's syndrome, Prenatal Diagn. 16, 605-613
29. Hayashi, M. and Kozu, H. (1995) Maternal urinary beta-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy, Prenatal Diagn. 15, 11-16